Abstract
Background In early 2020, Ecuador reported one of the highest surges of per capita deaths across the globe.
Methods We collected a comprehensive dataset containing individual death records between 2015 and 2020 from the Ecuadorian National Institute of Statistics and Census and the Ecuadorian Ministry of Government. We computed the number of excess deaths across time, geographical locations and demographic groups using Poisson regression methods.
Results Between January 1st and September 23rd, 2020, the number of excess deaths in Ecuador is 36,402 (95% CI: 35,762-36,827) or 208 per 105 population, which is 171% of the expected deaths in that period in a typical year. Only 20% of the excess deaths are attributable to confirmed COVID-19 deaths. Strikingly, in provinces that were most affected by COVID-19, such as Guayas and Santa Elena, the all-cause deaths are more than double the expected number of deaths that would have occurred in a normal year. The extent of excess deaths in men is higher than in women, and the number of excess deaths increases with age. Indigenous populations had the highest level of excess deaths among all ethnic groups.
Conclusions Overall, the exceptionally high level of excess deaths in Ecuador highlights the enormous burden and heterogeneous impact of COVID-19 on mortality especially in older age groups and indigenous populations in Ecuador that was not fully revealed by COVID-19 death counts. Together with the limited testing in Ecuador, our results suggest that the majority of the excess deaths were likely to be undocumented COVID-19 deaths.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The work is partially funded by the Laboratory Directed Research and Development (LDRD) Rapid Response Program through the Center for Nonlinear Studies at Los Alamos National Laboratory, and LDRD grants 20200699ER and 20210709ER. RK and SP would like to acknowledge funding from DARPA (HR0011938513), the Center for Nonlinear Studies. ERS was funded though NIH grant (R01AI135946). LC and NH would also like to acknowledge the US Department of Energy Office of Science through the National Virtual Biotechnology Laboratory, a consortium of national laboratories (Argonne, Los Alamos, Oak Ridge, and Sandia) focused on responding to COVID-19, with funding provided by the Coronavirus CARES Act. The funding source had no role in the design of the study, execution, analyses, interpretation of the data, or decision to publish.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee approval was obtained from the Ecuadorian Ministry of Public Health. The data analysis by the Los Alamos National Laboratory team was reviewed by that institution's IRB, and was determined to be exempt since all the data were collected from dead individuals for administrative purposes. Consent form were not required, no clinical trial was performed.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data underlying this article cannot be shared publicly due to Ecuador government regulations that the Ecuadorian Ministry of Public Health must approve the research protocol to release reusable COVID-19 datasets. The data may be shared on reasonable request to the corresponding authors and the Ecuadorian Civil Registry.
